Pediatric Oncology Program
525 East 68th Street, Payson-695
New York, NY 10065
The Pediatric Oncology Program at Weill Cornell Medicine provides up-to-date comprehensive care to children and adolescents with all forms of childhood cancer. Our specialists have extensive expertise in leukemias, lymphomas and sarcomas of bone and soft tissue. A child life therapist and an art therapist provide invaluable support to children and families getting their treatment in our newly renovated facility.
Services & Programs
Pediatric Cancer Program
Our healthcare team cares for children and adolescents with a variety of malignancies, with a focus on lymphoma or leukemia. An integrated team including physicians, a nurse practitioner, social worker, and child life therapist makes the experience as comfortable as possible for the child and family.
Adolescent and Young Adult (AYA) Lymphoma Program
We provide tailored, comprehensive diagnostic evaluation, treatment, and follow-up care for adolescents and young adults. Our center features a special program — in collaboration with lymphoma specialists in adult oncology — for young adults with lymphoma, who generally have better results when treated using pediatric therapies.
Childhood, Adolescent and Young Adult Survivorship and Late Effects Program
This program provides ongoing care to survivors of pediatric and young adult cancers after completion of therapy for complications from their treatment, and the effects of surgery, radiation, or chemotherapy that was administered.
Research
Clinical Trials
Eligible patients may have opportunities to participate in clinical trials of promising new therapies.
We are original members of the Children’s Oncology Group (COG), which is the premier multi-center pediatric cancer clinical trials group, devoted exclusively to childhood and adolescent research. Through COG, our patients have access to the latest targeted and molecular cancer agents.
Basic Science
Our faculty is studying the biology of cancer, with special emphasis on the development of lymphomas and tumor metastasis. These efforts have a translational focus, with the goal of using the information gathered to design more targeted therapies.
